Clinical Trial Update: Prospective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant Recipients [Phase 4]

View source ↗

Summary

A Phase 4 pilot study evaluating pre-transplant thymoglobulin to prevent rejection in living-donor kidney transplant recipients has completed and results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplant Rejection

Drugs mentioned

• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: University of Cincinnati | Conditions: Renal Transplant Rejection, Transplants and Implants | Phase 4 | Status: COMPLETED | Results posted: 2015-11-23